Quantcast

Latest ACE inhibitors Stories

2009-07-23 08:39:21

A particular class of medication used to treat high blood pressure could protect older adults against memory decline and other impairments in cognitive function, according to a newly published study from Wake Forest University School of Medicine.Research suggests that some of the drugs classified as angiotensin-converting enzyme (ACE) inhibitors, specifically those types of ACE inhibitors that affect the brain by crossing the blood-brain barrier, may reduce inflammation that could contribute...

2009-06-18 08:30:00

NANTONG CITY, China, June 18 /PRNewswire/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the "Company") (OTC Bulletin Board: SNBP) is pleased to announce today that it has received approval and authentication from the Trademark Bureau of China for its pre-surgical skeletal muscle relaxant Cisatracurium Besylate, marketed as Kutai, and its newly launched formulation of the anti-hypertension drug Perindopril, marketed as Yitai. Kutai has gained rapid market acceptance and is building strong brand...

2009-05-11 14:49:00

NANTONG CITY, China, May 11 /PRNewswire-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma" or, the "Company") is pleased to announce that it has received approval from the Chinese State Food and Drug Administration (SFDA) to manufacture and market its formulation of Perindopril, an anti-hypertension drug. Perindopril, used alone or in combination with other medications to treat high blood pressure, is the latest generation of a class of medications called...

2009-04-06 15:00:00

-Sinobiopharma to Market the World's First Perindopril in Capsule Form- NANJING, China, April 6 /PRNewswire-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma", or "the Company") (OTC Bulletin Board: SNBP) is pleased to announce that it has applied for a single Chinese patent for new drug compounds containing Perindopril, an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension) and heart attack in people with coronary artery disease. Sinobiopharma...

2009-04-03 00:42:42

Chicken soup with matzo balls, a popular home remedy for the common cold, may help control blood pressure, Japanese researchers suggest. Ai Saiga and colleagues cite previous studies indicating that chicken breast contains collagen proteins with effects similar to ACE inhibitors -- mainstay medications for treating high blood pressure. However, chicken breast contains such small amounts of the proteins that it could not be used to develop food and medical products for high blood pressure. The...

2009-01-22 09:27:15

While the treatment of heart failure has improved over the past two decades, a new study reported in the European Journal of Heart Failure finds that "the use of evidence-based treatments appears to be imbalanced according to the gender of the patient".In particular, the study found that female patients were less frequently treated with guideline-recommended medications (such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers ARBs) or beta-blockers) and that...

2009-01-16 13:47:33

The Heart and Stroke Foundation is warning some Canadians with high blood pressure that a drug combination may put them at risk. Guidelines from the Canadian Hypertension Education Program urge patients who have been prescribed a combination of ACE inhibitors and Angiotensin II Receptor Blockers to see their family physicians as soon as possible for a treatment change. These two popular categories of hypertension medication are each safe and effective treatments -- but not together, Dr....

2008-11-12 12:00:31

Novartis has presented new clinical data which showed that the first-in-class direct renin inhibitor Rasilez, known as Tekturna in the US, provides significantly greater blood pressure reductions in patients with high blood pressure aged 65 and over, compared to the angiotensin-converting enzyme inhibitor ramipril. Results from the Ageless study showed that Rasilez/Tekturna provides an additional reduction in systolic blood pressure of 2.3mmHg in patients aged 65 and over compared to the...

2008-09-01 12:00:04

Boehringer Ingelheim Pharmaceuticals has reported primary results from the Transcend trial, which showed that treatment with Micardis 80mg in patients receiving current standard of care resulted in an 8% reduction in the composite endpoint of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure. This reduction was not statistically significant (p=0.216; HR 0.92) compared to patients receiving placebo in addition to current standard of care....

2008-08-31 12:00:14

RIDGEFIELD, Conn., Aug. 31 /PRNewswire/ -- The primary results of the TRANSCEND(TM)* trial demonstrated that treatment with MICARDIS(R) (telmisartan) 80mg in patients receiving current standard of care resulted in an 8% reduction in the composite endpoint of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure. This reduction was not statistically significant (p=0.216; HR 0.92) compared to patients receiving placebo in addition to current...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related